Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 8/20 | 0.76 |
| ▸ | EPHA2 | P29317 | 4/20 | 0.76 |
| ▸ | CASP7 | P55210 | 3/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.76 |
| ▸ | VDR | P11473 | 3/20 | 0.76 |
| ▸ | TP53 | P04637 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | BLM | P54132 | 2/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.76 |
| ▸ | USP2 | O75604 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 2/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.76 |
| ▸ | MDM4 | O15151 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.76 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.76 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30594199 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL7915341 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL15292960 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL14983111 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL13356169 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL15185969 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL20392723 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL13588005 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL13811486 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR | |
| SCHEMBL15185970 | 1.00 | GPBAR1 (0.76) | GPBAR1EPHA2CASP7HIF1AVDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4133266-A1 | IMPROVED METHODS FOR EVALUATING LIVER FUNCTION | Hepquant, LLC (US) | 2023-02-15 | — | — | EP | claimed |
| US-20210318274-A1 | METHODS FOR EVALUATING LIVER FUNCTION | HepQuant, LLC | 2021-10-14 | — | — | US | claimed |
| CN-109831915-A | TLR 9-targeted spherical nucleic acid with strong anti-tumor activity | 埃克西奎雷股份有限公司 | 2019-05-31 | — | — | CN | claimed |
| US-6071670-A | PHOTORESIST RESIN COMPRISING PHOTOACID GENERATING COMPOUND AND AN ACID HYDROLYZABLE OLIGOMER HAVING ALICYCLIC OR POLYCONDENSED AROMATIC BACKBONE; ALKALI DEVELOPMENT WITH HIGH RESOLUTION, DRY ETCH RESISTANCE | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-06-06 | — | — | US | claimed |
| CN-114942292-B | Method for detecting content of plant sterol substances in blood based on liquid chromatography-tandem mass spectrometry technology | 中国医学科学院阜外医院 | 2023-09-12 | — | — | CN | disclosed |
| EP-4133266-A1 | IMPROVED METHODS FOR EVALUATING LIVER FUNCTION | Hepquant, LLC (US) | 2023-02-15 | — | — | EP | disclosed |
| CN-114942292-A | Method for detecting content of phytosterol substances in blood based on liquid chromatography-tandem mass spectrometry technology | 中国医学科学院阜外医院 | 2022-08-26 | — | — | CN | disclosed |
| US-20210318274-A1 | METHODS FOR EVALUATING LIVER FUNCTION | HepQuant, LLC | 2021-10-14 | — | — | US | disclosed |
| CN-109831915-A | TLR 9-targeted spherical nucleic acid with strong anti-tumor activity | 埃克西奎雷股份有限公司 | 2019-05-31 | — | — | CN | disclosed |
| CN-206192957-U | Test system and preceding processing apparatus of sample of synthetic absorption marker thing of cholesterol | 杭州量康科技有限公司 | 2017-05-24 | — | — | CN | disclosed |
| US-20120009122-A1 | GASTRIN RELEASING PEPTIDE COMPOUNDS | BRACCO IMAGING S.P.A. (IT) | 2012-01-12 | — | — | US | disclosed |
| US-20110280802-A1 | Linkers For Radiopharmaceutical Compounds | BRACCO IMAGING S.P.A. (IT) | 2011-11-17 | — | — | US | disclosed |
| US-20100009927-A1 | Anti-Inflammatory and Anti-Allergy Extracts from Nettle | HERBALSCIENCE GROUP LLC (US) | 2010-01-14 | — | — | US | disclosed |
| CN-100543136-C | Seed-specific USP promoter for expressing genes in plants | MONSANTO TECHNOLOGY LLC (US) | 2009-09-23 | — | — | CN | disclosed |
| US-20080200439-A1 | Establishing a test sample comprising a myocyte BK channel beta 1 subunit and measuring the interaction, effect, or combination thereof, of a candidate composition on test sample to thereby determine ability of candidate composition to modulate myocyte BK channel activity | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-08-21 | — | — | US | disclosed |
| WO-2008085492-A2 | METHODS AND COMPOSITIONS FOR MODULATING BK CHANNEL ACTIVITY AND VASODILATION | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-07-17 | — | — | WO | disclosed |
| CN-1728937-A | Time-specific seed promoters for expressing genes in plants | MONSANTO TECHNOLOGY LLC (US) | 2006-02-01 | — | — | CN | disclosed |
| CN-1685040-A | Seed-specific USP promoter for expressing genes in plants | MONSANTO TECHNOLOGY LLC (US) | 2005-10-19 | — | — | CN | disclosed |
| US-6071670-A | PHOTORESIST RESIN COMPRISING PHOTOACID GENERATING COMPOUND AND AN ACID HYDROLYZABLE OLIGOMER HAVING ALICYCLIC OR POLYCONDENSED AROMATIC BACKBONE; ALKALI DEVELOPMENT WITH HIGH RESOLUTION, DRY ETCH RESISTANCE | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0331477-A2 | Organic dye thin film and organic thin film element | KABUSHIKI KAISHA TOSHIBA (JP) | 1989-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009122-A1 | GASTRIN RELEASING PEPTIDE COMPOUNDS | GRPR, GIPR, CCKBR | GPBAR1 9/4885EPHA2 756/4885CASP7 2962/4885 |
| US-20110280802-A1 | Linkers For Radiopharmaceutical Compounds | VIP, QPCT, NPPA | GPBAR1 3590/4885EPHA2 1644/4885CASP7 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.